David Kerr - F1000 Section Head (since 16 November 2005)
Department of Clinical Pharmacology, University of Oxford, Oxford, UK
BIOGRAPHY
David J Kerr, CBE, MA MD DSc FRCP (Glas & Lon) FMedSciAcademic positions:
- Rhodes Professor of Clinical Pharmacology and Cancer Therapeutics
- Head of the Department of Clinical Pharmacology, University of Oxford
Any industry positions (last five years):
Professor Kerr has undertaken consultancy work for AstraZeneca, Roche, Sanofi-Aventis and Kudos
Research interests:
He has an international reputation for treatment for and research into colorectal cancer, and he is developing new approaches to cancer treatment which involve gene therapy.
Any other information:
- The quality of his work has been recognised by the award of several international prizes including the ESMO award and the first NHS Nye-Bevan award for innovation.
- He has published more than 350 articles in peer-reviewed journals and has contributed to many books on cancer.
- Professor Kerr has produced a 20 year plan for the future of the NHS in Scotland
- Editor-in-Chief of Annals of Oncology, Europe 's premier medical oncology journal
- Editorial broad of several other journals including Nature Clinical Practice Oncology.
- Fellow of the Academy of Medical Sciences in 2000
- Commander of the British Empire in 2002